Garrett K. Lam, M.D.

Dr. Lam joined ROC in July 2011.  He is board certified in both Ob/Gyn and Maternal-Fetal Medicine.  He received his MD from the University of Rochester, completed his residency training at Good Samaritan Medical Center in Phoenix, AZ and then went to the University of North Carolina-Chapel Hill for fellowship in Maternal Fetal Medicine. While there, he was trained in various in –utero procedures such as fetal blood sampling and intrauterine transfusion, fetal shunt placement and cord coagulation for parasitic twin gestations.  He also participated as the lead obstetrical surgeon or primary assistant for their pilot series of in –utero repair of fetal myelomeningocele.  Post fellowship, he traveled to Europe to attend the Eurofetus Consortium’s annual conferences on Twin Twin Transfusion Syndrome (TTTS), and completed a mini-sabbatical on laser photocoagulation for treatment of TTTS with doctors in both Belgium and the Netherlands. In 2008, along with Dr. William Clewell, he launched the first fetal therapy center in the Southwestern United States: the “ Maternal Fetal Center” of Phoenix Perinatal Associates and Banner Good Samaritan Medical Center. 

Aside from his work in fetal therapy, Dr. Lam has a deep interest in the studies of preeclampsia and postpartum hemorrhage. His work on the role of suppressor proteins in preeclamptic mothers has been published in the American Journal of Obstetrics and Gynecology.  He has also presented multiple abstracts for the International Society for the Study of Hypertension in Pregnancy, and has contributed to the postproduction modifications for a medical device used to treat postpartum hemorrhage.

Dr. Lam is a member of the Society for Maternal Fetal Medicine, International Society for the Study of Hypertension in Pregnancy, International Fetal Medicine and Surgery Society, and has served as on the Steering Committee for the North American Fetal Therapy Network.  He assists the Preeclampsia Foundation by serving on the “Ask the Experts” panel.  He has been recognized as a thought leader in the obstetrics and has been invited to conferences on the use of Fetal ST Analysis technology for intrapartum fetal monitoring, quantitative fetal fibronectin, market analysis for a new drug for pain control and the use of circulating cell free fetal nucleic acid methods for aneuploidy detection.  He also assists as a medical advisor with Glenveigh Medical and Surgical, a Chattanooga-based med-tech company. 

Locally, he has been appointed Assistant Program Director of the Ob/Gyn residency at the University of TN-Chattanooga, and previously served in a similar capacity with the University Of Arizona School Of Medicine.  In 2008, he was presented with the Good Samaritan Ob/Gyn Department award for Outstanding Teaching Member of the faculty, and in 2011 was recognized by the department for his contributions to resident education and research. Starting in 2008, he has been named by peers to the “Best Doctors in America” panel, & was recognized with the “Patients’ Choice” award by MDx Medical. 

Dr. Lam is also involved in multiple research projects, serving as primary investigator for multiple local and national studies.  He is published in multiple national and international medical journals, including AJOG, JSGI, Obstetrics and Gynecology and the Obstetrics and Gyncecology Survey.  He has contributed chapters to 5 different textbooks. His primary areas of research are in the fields of preeclampsia and fetal therapy. Outside of his professional life, he is devoted to spending as much time as possible with his wife and 3 boys, but is trying hard to return his golf game to respectable shape.